Global Insulin Sales Market Report 2024
The global Insulin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Animal Insulin
Regular Human Insulin
Insulin Analogue
Segment by Application
Short Acting
Intermediate Acting
Long Acting
Pre-Mix Insulin
The Insulin market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Insulin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang

Table of Content
1 Insulin Market Overview
1.1 Insulin Product Scope
1.2 Insulin Segment by Type
1.2.1 Global Insulin Sales by Type (2016 & 2021 & 2027)
1.2.2 Animal Insulin
1.2.3 Regular Human Insulin
1.2.4 Insulin Analogue
1.3 Insulin Segment by Application
1.3.1 Global Insulin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Insulin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Insulin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Insulin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Insulin Price Trends (2016-2027)
2 Insulin Estimates and Forecasts by Region
2.1 Global Insulin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Insulin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Insulin Sales Market Share by Region (2016-2021)
2.2.2 Global Insulin Revenue Market Share by Region (2016-2021)
2.3 Global Insulin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Insulin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Insulin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Insulin Estimates and Projections (2016-2027)
2.4.2 Europe Insulin Estimates and Projections (2016-2027)
2.4.3 China Insulin Estimates and Projections (2016-2027)
2.4.4 Japan Insulin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Insulin Estimates and Projections (2016-2027)
2.4.6 India Insulin Estimates and Projections (2016-2027)
3 Global Insulin Competition Landscape by Players
3.1 Global Top Insulin Players by Sales (2016-2021)
3.2 Global Top Insulin Players by Revenue (2016-2021)
3.3 Global Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin as of 2020)
3.4 Global Insulin Average Price by Company (2016-2021)
3.5 Manufacturers Insulin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Insulin Market Size by Type
4.1 Global Insulin Historic Market Review by Type (2016-2021)
4.1.1 Global Insulin Sales Market Share by Type (2016-2021)
4.1.2 Global Insulin Revenue Market Share by Type (2016-2021)
4.1.3 Global Insulin Price by Type (2016-2021)
4.2 Global Insulin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Insulin Sales Forecast by Type (2022-2027)
4.2.2 Global Insulin Revenue Forecast by Type (2022-2027)
4.2.3 Global Insulin Price Forecast by Type (2022-2027)
5 Global Insulin Market Size by Application
5.1 Global Insulin Historic Market Review by Application (2016-2021)
5.1.1 Global Insulin Sales Market Share by Application (2016-2021)
5.1.2 Global Insulin Revenue Market Share by Application (2016-2021)
5.1.3 Global Insulin Price by Application (2016-2021)
5.2 Global Insulin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Insulin Sales Forecast by Application (2022-2027)
5.2.2 Global Insulin Revenue Forecast by Application (2022-2027)
5.2.3 Global Insulin Price Forecast by Application (2022-2027)
6 North America Insulin Market Facts & Figures
6.1 North America Insulin Sales by Company
6.1.1 North America Insulin Sales by Company (2016-2021)
6.1.2 North America Insulin Revenue by Company (2016-2021)
6.2 North America Insulin Sales Breakdown by Type
6.2.1 North America Insulin Sales Breakdown by Type (2016-2021)
6.2.2 North America Insulin Sales Breakdown by Type (2022-2027)
6.3 North America Insulin Sales Breakdown by Application
6.3.1 North America Insulin Sales Breakdown by Application (2016-2021)
6.3.2 North America Insulin Sales Breakdown by Application (2022-2027)
7 Europe Insulin Market Facts & Figures
7.1 Europe Insulin Sales by Company
7.1.1 Europe Insulin Sales by Company (2016-2021)
7.1.2 Europe Insulin Revenue by Company (2016-2021)
7.2 Europe Insulin Sales Breakdown by Type
7.2.1 Europe Insulin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Insulin Sales Breakdown by Type (2022-2027)
7.3 Europe Insulin Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)
8 China Insulin Market Facts & Figures
8.1 China Insulin Sales by Company
8.1.1 China Insulin Sales by Company (2016-2021)
8.1.2 China Insulin Revenue by Company (2016-2021)
8.2 China Insulin Sales Breakdown by Type
8.2.1 China Insulin Sales Breakdown by Type (2016-2021)
8.2.2 China Insulin Sales Breakdown by Type (2022-2027)
8.3 China Insulin Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)
9 Japan Insulin Market Facts & Figures
9.1 Japan Insulin Sales by Company
9.1.1 Japan Insulin Sales by Company (2016-2021)
9.1.2 Japan Insulin Revenue by Company (2016-2021)
9.2 Japan Insulin Sales Breakdown by Type
9.2.1 Japan Insulin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Insulin Sales Breakdown by Type (2022-2027)
9.3 Japan Insulin Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Insulin Market Facts & Figures
10.1 Southeast Asia Insulin Sales by Company
10.1.1 Southeast Asia Insulin Sales by Company (2016-2021)
10.1.2 Southeast Asia Insulin Revenue by Company (2016-2021)
10.2 Southeast Asia Insulin Sales Breakdown by Type
10.2.1 Southeast Asia Insulin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Insulin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Insulin Sales Breakdown by Application
10.3.1 Southeast Asia M Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Pcs Sales Breakdown by Application (2022-2027)
11 India Insulin Market Facts & Figures
11.1 India Insulin Sales by Company
11.1.1 India Insulin Sales by Company (2016-2021)
11.1.2 India Insulin Revenue by Company (2016-2021)
11.2 India Insulin Sales Breakdown by Type
11.2.1 India Insulin Sales Breakdown by Type (2016-2021)
11.2.2 India Insulin Sales Breakdown by Type (2022-2027)
11.3 India Insulin Sales Breakdown by Application
11.3.1 India Insulin Sales Breakdown by Application (2016-2021)
11.3.2 India Insulin Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Insulin Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Corporation Information
12.1.2 Novo Nordisk Business Overview
12.1.3 Novo Nordisk Insulin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novo Nordisk Insulin Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Corporation Information
12.2.2 Eli Lilly Business Overview
12.2.3 Eli Lilly Insulin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly Insulin Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Sanofi-Aventis
12.3.1 Sanofi-Aventis Corporation Information
12.3.2 Sanofi-Aventis Business Overview
12.3.3 Sanofi-Aventis Insulin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi-Aventis Insulin Products Offered
12.3.5 Sanofi-Aventis Recent Development
12.4 Tonghua Dongbao
12.4.1 Tonghua Dongbao Corporation Information
12.4.2 Tonghua Dongbao Business Overview
12.4.3 Tonghua Dongbao Insulin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Tonghua Dongbao Insulin Products Offered
12.4.5 Tonghua Dongbao Recent Development
12.5 Ganlee
12.5.1 Ganlee Corporation Information
12.5.2 Ganlee Business Overview
12.5.3 Ganlee Insulin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ganlee Insulin Products Offered
12.5.5 Ganlee Recent Development
12.6 United Laboratory
12.6.1 United Laboratory Corporation Information
12.6.2 United Laboratory Business Overview
12.6.3 United Laboratory Insulin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 United Laboratory Insulin Products Offered
12.6.5 United Laboratory Recent Development
12.7 Jiangsu Wanbang
12.7.1 Jiangsu Wanbang Corporation Information
12.7.2 Jiangsu Wanbang Business Overview
12.7.3 Jiangsu Wanbang Insulin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Jiangsu Wanbang Insulin Products Offered
12.7.5 Jiangsu Wanbang Recent Development
...
13 Insulin Manufacturing Cost Analysis
13.1 Insulin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Insulin
13.4 Insulin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Insulin Distributors List
14.3 Insulin Customers
15 Market Dynamics
15.1 Insulin Market Trends
15.2 Insulin Drivers
15.3 Insulin Market Challenges
15.4 Insulin Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer